β2-AGONISTS
Summary
The
β2-agonists are the most offective
bronchodilators available .
β2-Adrenergic receptor stimulation
activates adenyl cuclase,which produces an increase in intraccllular
cyclic AMP. This in turn decreases unbound intracellular calcium ,
producings smooth muscle relaxation.Mast-cell membrane stabilization,
and skeletal muscle stimulation.β2 Adrenergic
stimulation also activatcs Na’ K’ ATPasc, produces
gluconeogenesis , and enhances insulin secretion, producing a mild to
moderate decrease in serum potassium concentration.
The Table compares the various
β-adrenergic agonists in terms of selectivity.Potency, oral activity , and duration of action.The β2-agonists are functional or
physiologic antagonists in that they relax airway smooth muscle
regardless of the mechanism for constriction.When administered in
equipotent doses , all the short-acting drugs will produce the same
intensity of response , the only differences will be in duration of
action and cardiac toxicity . All of the β
-agonists are more bronchoselective when administered by the aerosol
route , Differences in myocardial effect are discernible between
selective and nonslective agents even when administered as aerosols .
particularly at the higher doses used for acute severe asthma.
Table.
Relative Selectivity , Potency and Duration of Action of the B-Adrenegic
Agonists
Agent Selectivity
Duration of Action Oral
B1 B2
B3 Bronchodilation Protectionb
Activity
Potency a (h)
(h)
Isoproterenol
Metlaproterenol
Losetharine
Albuterol
Bitolterol
Pirbuterol
Terbutaline
Formoterol
Salmeterol |
+ + + +
| | |
+ +
+ |
+ + + +
| | |
+ + +
+ + + +
+ + + +
|
1
15
6
2
5
5
4
0.24
0.25 |
0.5-2.0
3-4
0.5-2.0
4-8
4-8
4-8
4-8
>12
>12 |
0.5-1.0
1-2
0.5-1.0
2-4
2-4
2-4
2-4
>12
>12 |
No
Yes
No
Yes
No
Yes
Yes
Yes
Yes |
a)
Relative molar potency :
β 1 most patent.
b)
b)
Protection refers to the duration of
time that bronchocoustriction may be prevented
|